EMD SERONO

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

First Posted Date
2006-02-15
Last Posted Date
2013-08-05
Lead Sponsor
EMD Serono
Target Recruit Count
677
Registration Number
NCT00292266

Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients

Completed
Conditions
First Posted Date
2005-12-06
Last Posted Date
2013-11-14
Lead Sponsor
EMD Serono
Target Recruit Count
509
Registration Number
NCT00262314
Locations
🇺🇸

Registrat Inc, Lexington, Kentucky, United States

A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

First Posted Date
2005-11-07
Last Posted Date
2013-08-06
Lead Sponsor
EMD Serono
Target Recruit Count
257
Registration Number
NCT00249860

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

First Posted Date
2005-09-21
Last Posted Date
2014-02-07
Lead Sponsor
EMD Serono
Target Recruit Count
1326
Registration Number
NCT00213135

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

First Posted Date
2005-09-21
Last Posted Date
2018-07-17
Lead Sponsor
EMD Serono
Target Recruit Count
271
Registration Number
NCT00213148
Locations
🇺🇸

Local US Medical Information, Rockland, Massachusetts, United States

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

First Posted Date
2005-08-22
Last Posted Date
2013-10-25
Lead Sponsor
EMD Serono
Target Recruit Count
45
Registration Number
NCT00132522
Locations
🇺🇸

Dartmouth Medical School, Pharmacology & Toxicology Dept. of Medicine, Lebanon, New Hampshire, United States

🇺🇸

Fox Chase Cancer Oncology Department of Medical Oncology, Philadelphia, Pennsylvania, United States

🇺🇸

City of Hope, Durate, California, United States

and more 2 locations

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

First Posted Date
2005-05-27
Last Posted Date
2018-04-06
Lead Sponsor
EMD Serono
Target Recruit Count
150
Registration Number
NCT00111839
Locations
🇺🇸

University of Southern California/Norris Cancer Center, Los Angeles, California, United States

🇺🇸

Peachtree Hematology and Oncology, Atlanta, Georgia, United States

🇺🇸

Georgia Cancer Specialists, Tucker, Georgia, United States

and more 40 locations
© Copyright 2024. All Rights Reserved by MedPath